Comarestol 50 µg/ 5 mg/ml Ophthalmic Solution
PDF Leaflet Revision Date: 12 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of intraocular pressure in open angle glaucoma and ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) once daily.
Onset of Action / Duration
Onset: 1 hour, Duration: up to 24 hours
Special Populations
- Elderly
- Patients with cardiovascular diseases
- Patients with respiratory disorders
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Concomitant use with other beta-blockers
- Hypoglycaemic medicines
- Phenothiazines
Contraindications
- Hypersensitivity to components
- Reactive airway disease
- Cardiac failure
Common side effects
- Eye irritation
- Increased iris pigmentation
- Headache
Counselling Points
- Inform about potential eye color change
- Avoid contact lenses during application
- Monitor for respiratory symptoms
Serious warnings
- Systemic absorption may occur
- Caution in patients with asthma
- Potential for severe bradycardia
Important Disclaimer
The Comarestol 50 µg/ 5 mg/ml Ophthalmic Solution professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
